AU2002345932A1 - Compositions and methods for treating atherosclerosis - Google Patents
Compositions and methods for treating atherosclerosisInfo
- Publication number
- AU2002345932A1 AU2002345932A1 AU2002345932A AU2002345932A AU2002345932A1 AU 2002345932 A1 AU2002345932 A1 AU 2002345932A1 AU 2002345932 A AU2002345932 A AU 2002345932A AU 2002345932 A AU2002345932 A AU 2002345932A AU 2002345932 A1 AU2002345932 A1 AU 2002345932A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- treating atherosclerosis
- atherosclerosis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89336601A | 2001-06-26 | 2001-06-26 | |
US09/893,366 | 2001-06-26 | ||
PCT/US2002/020350 WO2003002061A2 (en) | 2001-06-26 | 2002-06-26 | Compositions and methods for treating atherosclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002345932A1 true AU2002345932A1 (en) | 2003-03-03 |
Family
ID=25401440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002345932A Abandoned AU2002345932A1 (en) | 2001-06-26 | 2002-06-26 | Compositions and methods for treating atherosclerosis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002345932A1 (en) |
WO (1) | WO2003002061A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101843905B (en) * | 2009-03-27 | 2015-04-08 | 中国医学科学院基础医学研究所 | Application of PON gene cluster in preparing medicaments for treating atherosclerosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000047734A1 (en) * | 1999-02-12 | 2000-08-17 | President And Fellows Of Harvard College | Inhibiting formation of atherosclerotic lesions |
-
2002
- 2002-06-26 WO PCT/US2002/020350 patent/WO2003002061A2/en not_active Application Discontinuation
- 2002-06-26 AU AU2002345932A patent/AU2002345932A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003002061A3 (en) | 2003-11-06 |
WO2003002061B1 (en) | 2003-12-24 |
WO2003002061A2 (en) | 2003-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001245437A1 (en) | Lightweight methods and compositions for well treating | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2002364364A1 (en) | Method of treating apoptosis and compositions thereof | |
GB0201866D0 (en) | Method and compositions for disinfecting hard surfaces | |
AU2001286651A1 (en) | Microparticle composition and method | |
AU2003212894A1 (en) | Compositions and methods for treating diarrhea | |
AU2002236626A1 (en) | Compositions and methods for treating hyperpigmentation | |
AU2003297573A1 (en) | Compositions and methods for treating transplants | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2001233932A1 (en) | Method and composition | |
AU2003238905A1 (en) | Surface treating compositions and methods for using same | |
AU2002303552A1 (en) | Methods and compositions for prevention of angioproliferation | |
AU2001238179A1 (en) | Method and compositions for treating hepatocellular cancer | |
AU2002310046A1 (en) | Compositions and methods for inhibiting metastasis | |
AU2003214920A1 (en) | Methods and compositions for treating hematological disorders | |
AU2001283226A1 (en) | Methods and compositions for inhibiting rad51 | |
AU2002239775A1 (en) | Chemical-library composition and method | |
AU2002365136A1 (en) | Compositions and methods for controlled release | |
AU2002305700A1 (en) | Composition and method for treating cells | |
AUPQ872800A0 (en) | Compositions and methods for treating cardiovascular disorders | |
AU2002345932A1 (en) | Compositions and methods for treating atherosclerosis | |
AU2002359869A1 (en) | Pak5-related compositions and methods | |
AU2002342188A1 (en) | Methods and compositions for treating flavivirus-mediated disease | |
AU2002246221A1 (en) | Method and composition | |
AU2002360454A1 (en) | Methods and compositions for treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |